scholarly journals MiR-92a and miR-486 are potential diagnostic biomarkers for mercury poisoning and jointly sustain NF-κB activity in mercury toxicity

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Enmin Ding ◽  
Jun Guo ◽  
Ying Bai ◽  
Hengdong Zhang ◽  
Xin Liu ◽  
...  
Author(s):  
Andrew Taylor ◽  
Vincent Marks

A review of referrals to a regional heavy metals centre for possible mercury poisoning was made. Samples were received either from subjects who were well but were known to have some contact with mercury or from patients with an illness under investigation but undiagnosed. The problems associated with diagnosis of mercury toxicity in the absence of known exposure are illustrated by two case reports.


2012 ◽  
Vol 2012 ◽  
pp. 1-12 ◽  
Author(s):  
Ige Joseph Kade

Mercury is an environmental poison, and the damage to living system is generally severe. The severity of mercury poisoning is consequent from the fact that it targets the thiol-containing enzymes, irreversibly oxidizing their critical thiol groups, consequently leading to an inactivation of the enzyme. The Na+/K+-ATPase is a sulfhydryl protein that is sensitive to Hg2+assault. On the other hand, organoseleniums are a class of pharmacologically promising compounds with potent antioxidant effects. While Hg2+oxidizes sulfhydryl groups of Na+/K+-ATPase underin vitroandin vivoconditions, the organoselenium compounds inhibit Na+/K+-ATPasein vitrobut enhance its activities underin vivoconditions with concomitant increase in the level of endogenous thiols. Paradoxically, it appears that these two thiol oxidants can be used to counteract one another underin vivoconditions, and this hypothesis serves as the basis for this paper.


Author(s):  
Afaf Attia ◽  
Sohayla Attalla ◽  
Reham Shaat ◽  
Enas Hmmad ◽  
Mohammed El-Dafrawy

2020 ◽  
Vol 26 ◽  
Author(s):  
Yini Ma ◽  
Xiu Cao ◽  
Guojuan Shi ◽  
Tianlu Shi

: MicroRNAs (miRNAs) play a vital role in the onset and development of many diseases, including cancers. Emerging evidence shows that numerous miRNAs have the potential to be used as diagnostic biomarkers for cancers, and miRNA-based therapy may be a promising therapy for the treatment of malignant neoplasm. MicroRNA-145 (miR-145) has been considered to play certain roles in various cellular processes, such as proliferation, differentiation and apoptosis, via modulating expression of direct target genes. Recent reports show that miR-145 participates in the progression of digestive system cancers, and plays crucial and novel roles for cancer treatment. In this review, we summarize the recent knowledge concerning the function of miR-145 and its direct targets in digestive system cancers. We discuss the potential role of miR-145 as valuable biomarkers for digestive system cancers and how miR-145 regulates these digestive system cancers via different targets to explore the potential strategy of targeting miR-145.


Sign in / Sign up

Export Citation Format

Share Document